It is time to push aside opioids and OTC analgesic pills, because the (Salonpas) patches are coming! Hisamitsu America is proud to announce that May 18th, 2019 is “Salonpas Day” which signals a day free from pain from the world leader in medicinal pain patches. This year, employees from Hisamitsu America will distribute thousands of Salonpas Pain Relieving Patches and Salonpas Lidocaine Pain Relieving Gel-Patches at the Greenway Open Market in the Wharf District Parks, as well as key landmarks around Harvard Square. “Just as Paul Revere warned Bostonians that the ‘British are coming,’ Salonpas is alerting everyone that our patches are coming,” says John Incledon, President, Hisamitsu America, the marketers of Salonpas, the world’s number one pain patch brand. “Under the banner of Salonpathy, our mission is to improve the quality of life through patch. We are excited to be delivering pain relief to the hard-working people of Boston.”
Oral pain relievers, mainly opioids, and NSAIDs are leading causes of serious adverse events; hospitalization for CV & GI risk and death. The Center for Disease Control (CDC) reports that since 2000, over 200,000 people in the USA have died from overdose of prescription opioids. In 2016, the CDC issued guidance to physicians managing chronic pain without opioids, that topical analgesics can be an alternative first line therapy.
Announcing the availability of Salonpas-HOT, the top-selling product in the Topical Analgesic category, in a new value pack that includes three folded patches in a pack. Salonpas-HOT releases capsaicin, a natural, odor free pain reliever, for long lasting pain relief up to eight hours. Capsaicin, the compound found in chili, cayenne, and jalapeno peppers, is used topically by many medical professionals to help relieve minor pain associated with arthritis or muscle sprains and strains. “With all the opioid and Rx NSAID issues our country is facing, it is more important than ever to identify safer options to treat pain,” adds Incledon. “The CDC has identified Topical Analgesics as a first line option in lieu of oral systemic analgesics and opioids, and specifically mention Capsaicin as one of the potential active ingredients.”
Disclaimer: I received one or more of the products or services mentioned above for free in the hope that I would mention it on my blog. Regardless, I only recommend products or services I use personally and believe will be good for my readers. I am disclosing this in accordance with the Federal Trade Commission's 16 CFR, Part 255: "Guides Concerning the Use of Endorsements and Testimonials in Advertising.